Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
Journey Medical (US:DERM) Newsfilter·2024-07-11 20:05SCOTTSDALE, Ariz., July 11, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) ("Journey Medical"), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration ("FDA")-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that on July 9, 2024, it appointed Michael C. Pearce to its Board of Directors. "We are very pleased to welcome Mike to our Board of Directors," said Cla ...